TempraMed Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
10
- Stock Symbol
-
VIVI
- Share Price
-
$0.22
- (As of Friday Closing)
TempraMed General Information
Description
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
Contact Information
Website
www.tempramed.comCorporate Office
- 19481 South East 14th Street
- Sammamish, WA 98075
- United States
Corporate Office
- 19481 South East 14th Street
- Sammamish, WA 98075
- United States
TempraMed Timeline
TempraMed Stock Performance
As of 13-Nov-2026, TempraMed’s stock price is $0.22. Its current market cap is $17.5M with 80.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.22 | $0.23 | $0.17 - $1.02 | $17.5M | 80.4M | 12.5K | -$0.27 |
TempraMed Financials Summary
As of 30-Jun-2026, TempraMed has a trailing 12-month revenue of $1.95M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 33,533 | 56,794 | ||
| Revenue | 1,947 | 1,843 | 2,264 | 0 |
| EBITDA | (20,173) | (17,649) | (3,004) | (3) |
| Net Income | (20,402) | (18,191) | (3,354) | (3) |
| Total Assets | 1,120 | 1,842 | 469 | 0 |
| Total Debt | 1,590 | 1,261 | 2,517 | 0 |
TempraMed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TempraMed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
TempraMed Patents
TempraMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12746342-B2 | Apparatuses, systems and methods for storing a substance | Active | 02-Feb-2021 | ||
| US-20240091458-A1 | Apparatuses, systems and methods for storing a substance | Active | 02-Feb-2021 |
TempraMed Signals
TempraMed Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
TempraMed ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
TempraMed FAQs
-
When was TempraMed founded?
TempraMed was founded in 2014.
-
Where is TempraMed headquartered?
TempraMed is headquartered in Sammamish, WA.
-
What is the size of TempraMed?
TempraMed has 10 total employees.
-
What industry is TempraMed in?
TempraMed’s primary industry is Medical Supplies.
-
Is TempraMed a private or public company?
TempraMed is a Public company.
-
What is TempraMed’s stock symbol?
The ticker symbol for TempraMed is VIVI.
-
What is the current stock price of TempraMed?
As of 13-Nov-2026 the stock price of TempraMed is $0.22.
-
What is the current market cap of TempraMed?
The current market capitalization of TempraMed is $17.5M.
-
What is TempraMed’s current revenue?
The trailing twelve month revenue for TempraMed is $1.95M.
-
What is TempraMed’s annual earnings per share (EPS)?
TempraMed’s EPS for 12 months was -$0.27.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process